Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 1/20 | 0.50 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.50 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.50 |
| ▸ | LTA4H | P09960 | 2/20 | 0.42 |
| ▸ | GPR88 | Q9GZN0 | 1/20 | 0.41 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.41 |
| ▸ | FNTA | P49354 | 2/20 | 0.41 |
| ▸ | FNTB | P49356 | 2/20 | 0.41 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.41 |
| ▸ | KRAS | P01116 | 1/20 | 0.41 |
| ▸ | ALPI | P09923 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | XIAP | P98170 | 1/20 | 0.40 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.40 |
| ▸ | ACE | P12821 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL15201184 | 0.98 | ANPEP (0.48) | ANPEPRNPEPDNPEPLTA4HGPR88 | |
| SCHEMBL258735 | 0.89 | ANPEP (0.44) | ANPEPRNPEPDNPEPLTA4HFNTA | |
| SCHEMBL61200 | 0.87 | ANPEP (0.43) | ANPEPRNPEPDNPEPLTA4HFNTA | |
| SCHEMBL28194148 | 0.87 | ANPEP (0.42) | ANPEPRNPEPDNPEPLTA4HGPR88 | |
| SCHEMBL7999637 | 0.85 | ANPEP (0.51) | ANPEPRNPEPDNPEPLTA4HGPR88 | |
| SCHEMBL39530 | 0.84 | ANPEP (0.37) | ANPEPRNPEPDNPEPLTA4HFNTA | |
| SCHEMBL27468737 | 0.83 | ANPEP (0.53) | ANPEPRNPEPDNPEPLTA4HGPR88 | |
| SCHEMBL19974077 | 0.81 | ANPEP (0.51) | ANPEPRNPEPDNPEPLTA4HGPR88 | |
| Phenylalanine SCHEMBL907512 | 0.81 | SLC7A5 (0.58) | ANPEPRNPEPDNPEPLTA4HFNTA | |
| D-Phenylalanine SCHEMBL6450960 | 0.81 | SLC7A5 (0.58) | ANPEPRNPEPDNPEPLTA4HFNTA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3497445-A2 | MICROPATTERNING ASSEMBLY, METHODS FOR MICROPATTERNING, AND MICROPATTERNED DEVICES | Institute of Science and Technology Austria (AT) | 2019-06-19 | — | — | EP | claimed |
| WO-2018029315-A2 | MICROPATTERNING ASSEMBLY, METHODS FOR MICROPATTERNING, AND MICROPATTERNED DEVICES | IST AUSTRIA - INSTITUTE OF SCIENCE AND TECHNOLOGY AUSTRIA (AT) | 2018-02-15 | — | — | WO | claimed |
| EP-1599226-A4 | A METHOD OF DIAGNOSIS AND TREATMENT | MEDVET SCIENCE PTY LTD (AU) | 2007-11-21 | — | — | EP | claimed |
| EP-1599226-A1 | A METHOD OF DIAGNOSIS AND TREATMENT | MEDVET SCIENCE PTY. LTD. (AU) | 2005-11-30 | — | — | EP | claimed |
| WO-2004073739-A1 | A METHOD OF DIAGNOSIS AND TREATMENT | MEDVET SCIENCE PTY. LTD. (AU) | 2004-09-02 | — | — | WO | claimed |
| EP-4373506-A1 | EXTRACELLULAR VESICLES FROM MICROALGAE, THEIR PREPARATION, AND USES | AGS Therapeutics SAS (FR) | 2024-05-29 | — | — | EP | disclosed |
| WO-2023001894-A9 | EXTRACELLULAR VESICLES FROM MICROALGAE, THEIR PREPARATION, AND USES | AGS THERAPEUTICS SAS (FR) | 2024-03-28 | — | — | WO | disclosed |
| WO-2023232976-A1 | EXTRACELLULAR VESICLES FROM GENETICALLY-MODIFIED MICROALGAE CONTAINING ENDOGENOUSLY-LOADED CARGO, THEIR PREPARATION, AND USES | AGS THERAPEUTICS SAS (FR) | 2023-12-07 | — | — | WO | disclosed |
| CN-111330023-B | Magnetic nano composite material and preparation method and application thereof | 中国科学院宁波材料技术与工程研究所慈溪生物医学工程研究所 | 2023-01-31 | — | — | CN | disclosed |
| WO-2023001894-A1 | EXTRACELLULAR VESICLES FROM MICROALGAE, THEIR PREPARATION, AND USES | AGS THERAPEUTICS SAS (FR) | 2023-01-26 | — | — | WO | disclosed |
| CN-114209847-B | Secondary nanocrystallized albumin paclitaxel medicament and application thereof | 徐州医科大学 | 2022-12-13 | — | — | CN | disclosed |
| CN-114209847-A | Secondary nanocrystallized albumin paclitaxel medicament and application thereof | 徐州医科大学 | 2022-03-22 | — | — | CN | disclosed |
| WO-1993006229-A1 | CLONING OF cDNA ENCODING A FUNCTIONAL HUMAN INTERLEUKIN-8 RECEPTOR | THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1993-04-01 | — | — | WO | disclosed |
| US-5169865-A | Method and composition for calcium binding, translocation and mediating | SEABRIGHT CORPORATION LIMITED (CA) | 1992-12-08 | — | — | US | disclosed |
| EP-0438497-A4 | VASOPERMEABILITY-ENHANCING CONJUGATES | — | 1992-02-26 | — | — | EP | disclosed |
| WO-1992001464-A1 | INHIBITION OF MAC-1 RECEPTOR BINDING TO FIBRINOGEN USING D30 HOMOLOGS | THE SCRIPPS RESEARCH INSTITUTE (US) | 1992-02-06 | — | — | WO | disclosed |
| EP-0438497-A1 | VASOPERMEABILITY-ENHANCING CONJUGATES. | UNIV SOUTHERN CALIFORNIA (US) | 1991-07-31 | — | — | EP | disclosed |
| EP-0398143-A1 | Labeled chemotactic peptides to image focal sites of infection or inflammation | THE GENERAL HOSPITAL CORPORATION (US) | 1990-11-22 | — | — | EP | disclosed |
| WO-1990013317-A1 | LABELED CHEMOTATIC PEPTIDES TO IMAGE FOCAL SITES OF INFECTION OR INFLAMMATION | THE GENERAL HOSPITAL CORPORATION (US) | 1990-11-15 | — | — | WO | disclosed |
| WO-1990003801-A1 | VASOPERMEABILITY-ENHANCING CONJUGATES | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 1990-04-19 | — | — | WO | disclosed |